The in vitro pharmacological profile of prucalopride, a novel enterokinetic compound

Author： Briejer M.R.   Bosmans J.-P.   Van Daele P.   Jurzak M.   Heylen L.   Leysen J.E.   Prins N.H.   Schuurkes J.A.J.  

Publisher： Elsevier

ISSN： 0014-2999

Source： European Journal of Pharmacology, Vol.423, Iss.1, 2001-06, pp. : 71-83

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacological profile of a novel series of NK 1 antagonists. In vitro and in vivo potency of benzimidazolone derivatives

By Remond G.   Portevin B.   Bonnet J.   Canet E.   Regoli D.   De Nanteuil G.  

European Journal of Medicinal Chemistry, Vol. 32, Iss. 11, 1997-11 ,pp. : 843-868

Elsevier

Access to resources Recommend Favorite

Pharmacological profile of T-0632, a novel potent and selective CCK A receptor antagonist, in vitro

By Taniguchi H.   Yazaki N.   Endo T.   Nagasaki M.  

European Journal of Pharmacology, Vol. 304, Iss. 1, 1996-05 ,pp. : 147-154

Elsevier

Access to resources Recommend Favorite

Pharmacological profile of ASP8497, a novel, selective, and competitive dipeptidyl peptidase-IV inhibitor, in vitro and in vivo

By Someya Yuka  

Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 377, Iss. 3, 2008-05 ,pp. : 209-217

Springer Publishing Company

Access to resources Recommend Favorite

PDE5 Inhibitors: In Vitro and In Vivo Pharmacological Profile

By  

Current Pharmaceutical Design, Vol. 15, Iss. 30, 2009-10 ,pp. : 3464-3475

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacological profile of ramosetron, a novel therapeutic agent for IBS

By Hirata T.   Funatsu T.   Keto Y.   Nakata M.   Sasamata M.  

Inflammopharmacology, Vol. 15, Iss. 1, 2007-02 ,pp. : 5-9

Springer Publishing Company

Access to resources Recommend Favorite